Lysosomal Storage Diseases Market By Therapy Type (substrate Reduction Therapy, Enzyme Replacement Therapy, Stem Cell Therapy, Others), Indication (mucopolysaccharidosis, Gaucher\'s Diseases, Pompe’s Syndrome, Fabry Diseases Others) And End User (hospitals, Clinics) - Global Industry Analysis & Forecast To 2023
Published On : July 2018 Pages : 185 Category: Pharmaceuticals Report Code : HC071083
Industry Outlook and Trend Analysis
The Lysosomal Storage Diseases Market is expected to garner a substantial market by 2023, while registering itself at a significant compound annual growth rate (CAGR) during the forecast period. Lysosomal stockpiling sicknesses are a group of around 50 uncommon acquired metabolic issues that is the result of defects in lysosomal function. Lysosomes are sacs of compounds inside cells that process huge molecules and pass the pieces on to different parts of the cell to recycle. This procedure needs a few fundamental enzymes. If any of the enzymes are defective, due to mutation, the vast molecules collect inside the cell, in the end executing it. The lysosome is usually alluded to as the cell's reusing focus since it forms undesirable material into substances that the cell can utilize. Lysosomes separate this unwanted matter by chemicals, exceptionally particular proteins fundamental for survival. Lysosomal issues are typically activated when a specific compound exists in too little a sum or is missing altogether.
Drivers and Restraints
An expanding rate of diagnosis because of developing awareness and money related motivating forces for orphan medication improvement to recoup R&D costs is the essential factor energizing the development of the worldwide lysosomal storage diseases therapeutics market. Different components driving the worldwide interest for lysosomal storage diseases incorporate a speedier take-up and quicker access to market, premium product pricing, and expanding focus of pharmaceutical organizations in the R&D of medications for the treatment of uncommon maladies. Nonetheless, heterogeneity of the infection prompting under-diagnoses of lysosomal storage diseases, less options for treatment, and high expense of treatment are factors prone to hamper the development of the growth of the market over the forecast period.
Market Segmentation
The Lysosomal Storage Diseases Market is segmented based on therapy type into Substrate Reduction Therapy, Enzyme Replacement Therapy, Stem Cell Therapy, Others. Based on indication the market is segmented into Mucopolysaccharidosis, Gaucher's Diseases, Pompe’s Syndrome, Fabry Diseases Others. On the basis of end user the market is segmented into Hospitals and Clinics.
Regional Outlook and Trend Analysis
On the basis of value, Europe is assessed to be the prevailing business sector in the worldwide lysosomal storage diseases market in 2017 and is anticipated to grow tremendously over the forecast period. North America is anticipated to be the second most lucrative market in the worldwide lysosomal storage diseases market over the figure time frame. In 2017, North America accounted for 32.2% income share of the worldwide lysosomal storage diseases market.
Competitive Insights
The major players in the market are Sanofi, Amicus Therapeutics, BioMarin Pharmaceutical, Shire, Protalix BioTherapeutics, Actelion, Raptor Pharmaceuticals Corp and Pfizer. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Lysosomal Storage Diseases Market is segmented by regions as follows-
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Lysosomal Storage Diseases Market, By Therapy, Estimates and Forecast, 2014-2023($Billion)
o Substrate Reduction Therapy
o Enzyme Replacement Therapy
o Stem Cell Therapy
o Others
· Lysosomal Storage Diseases Market, By Indication, Estimates and Forecast, 2014-2023($Billion)
o Mucopolysaccharidosis
o Gaucher's Diseases
o Pompe’s Syndrome
o Fabry Disease
o Others
· Lysosomal Storage Diseases Market, By End User, Estimates and Forecast, 2014-2023($Billion)
o Hospitals
o Clinics
· Lysosomal Storage Diseases Market, By Region, Estimates and Forecast, 2014-2023($Billion)
o North America
§ North America Lysosomal Storage Diseases Market, By Country
o U.S. Lysosomal Storage Diseases Market
o Canada Lysosomal Storage Diseases Market
o Mexico Lysosomal Storage Diseases Market
o Europe
§ Europe Lysosomal Storage Diseases Market, By Country
o Germany Lysosomal Storage Diseases Market
o UK Lysosomal Storage Diseases Market
o France Lysosomal Storage Diseases Market
o Russia Lysosomal Storage Diseases Market
o Italy Lysosomal Storage Diseases Market
o Rest of Europe Lysosomal Storage Diseases Market
o Asia-Pacific
§ Asia-Pacific Lysosomal Storage Diseases Market, By Country
o China Lysosomal Storage Diseases Market
o Japan Lysosomal Storage Diseases Market
o South Korea Lysosomal Storage Diseases Market
o India Lysosomal Storage Diseases Market
o Southeast Asia Lysosomal Storage Diseases Market
o Rest of Asia-Pacific Lysosomal Storage Diseases Market
o South America
§ South America Lysosomal Storage Diseases Market
o Brazil Lysosomal Storage Diseases Market
o Argentina Lysosomal Storage Diseases Market
o Columbia Lysosomal Storage Diseases Market
o South Africa Lysosomal Storage Diseases Market
o Rest of South America Lysosomal Storage Diseases Market
o Middle East and Africa
§ Middle East and Africa Lysosomal Storage Diseases Market
o Saudi Arabia Lysosomal Storage Diseases Market
o UAE Lysosomal Storage Diseases Market
o Egypt Lysosomal Storage Diseases Market
o Nigeria Lysosomal Storage Diseases Market
o South Africa Lysosomal Storage Diseases Market
Rest of MEA Lysosomal Storage Diseases Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Lysosomal Storage Diseases Market, By Therapy
5.1. Introduction
5.2. Global Lysosomal Storage Diseases Revenue and Market Share By Therapy (2017-2027)
5.2.1. Global Lysosomal Storage Diseases Revenue and Revenue Share By Therapy (2017-2027)
5.3. Stem Cell Therapy
5.3.1. Global Stem Cell Therapy Revenue and Growth Rate (2017-2027)
5.4. Enzyme Replacement Therapy
5.4.1. Global Enzyme Replacement Therapy Revenue and Growth Rate (2017-2027)
5.5. Substrate Reduction Therapy
5.5.1. Global Substrate Reduction Therapy Revenue and Growth Rate (2017-2027)
5.6. Others
5.6.1. Global Others Revenue and Growth Rate (2017-2027)
6. Lysosomal Storage Diseases Market, By Indication
6.1. Introduction
6.2. Global Lysosomal Storage Diseases Revenue and Market Share By Indication (2017-2027)
6.2.1. Global Lysosomal Storage Diseases Revenue and Revenue Share By Indication (2017-2027)
6.3. Pompe’s Syndrome
6.3.1. Global Pompe’s Syndrome Revenue and Growth Rate (2017-2027)
6.4. Gaucher’s Disease
6.4.1. Global Gaucher’s Disease Revenue and Growth Rate (2017-2027)
6.5. Fabry Disease
6.5.1. Global Fabry Disease Revenue and Growth Rate (2017-2027)
6.6. Mucopolysaccharidosis
6.6.1. Global Mucopolysaccharidosis Revenue and Growth Rate (2017-2027)
6.7. Others
6.7.1. Global Others Revenue and Growth Rate (2017-2027)
7. Lysosomal Storage Diseases Market, By End User
7.1. Introduction
7.2. Global Lysosomal Storage Diseases Revenue and Market Share By End User (2017-2027)
7.2.1. Global Lysosomal Storage Diseases Revenue and Revenue Share By End User (2017-2027)
7.3. Hospitals
7.3.1. Global Hospitals Revenue and Growth Rate (2017-2027)
7.4. Clinics
7.4.1. Global Clinics Revenue and Growth Rate (2017-2027)
8. Lysosomal Storage Diseases Market, By Region
8.1. Introduction
8.2. Global Lysosomal Storage Diseases Revenue and Market Share by Regions
8.2.1. Global Lysosomal Storage Diseases Revenue by Regions (2017-2027)
8.3. North America Lysosomal Storage Diseases by Countries
8.3.1. North America Lysosomal Storage Diseases Revenue and Growth Rate (2017-2027)
8.3.2. North America Lysosomal Storage Diseases Revenue by Countries (2017-2027)
8.3.3. North America Lysosomal Storage Diseases Revenue (Million USD) by Countries (2017-2027)
8.3.4. U.S.
8.3.4.1. United States Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Canada
8.3.5.1. Canada Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.6. Mexico
8.3.6.1. Mexico Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Lysosomal Storage Diseases by Countries
8.4.1. Europe Lysosomal Storage Diseases Revenue and Growth Rate (2017-2027)
8.4.2. Europe Lysosomal Storage Diseases Revenue by Countries (2017-2027)
8.4.3. Europe Lysosomal Storage Diseases Revenue (Million USD) by Countries (2017-2027)
8.4.4. Germany
8.4.4.1. Germany Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. France
8.4.6.1. France Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Russia
8.4.7.1. Russia Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Italy
8.4.8.1. Italy Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.9. Rest of Europe
8.4.9.1. Rest of Europe Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific
8.5.1. Asia-Pacific Lysosomal Storage Diseases Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Lysosomal Storage Diseases Revenue by Countries (2017-2027)
8.5.3. Asia-Pacific Lysosomal Storage Diseases Revenue (Million USD) by Countries (2017-2027)
8.5.4. China
8.5.4.1. China Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Japan
8.5.5.1. Japan Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5.2.
8.5.6. Korea
8.5.6.1. Korea Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. India
8.5.7.1. India Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Southeast Asia
8.5.8.1. Southeast Asia Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.9. Rest of Asia-Pacific
8.5.9.1. Rest of Asia-Pacific Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America
8.6.1. South America Lysosomal Storage Diseases Revenue and Growth Rate (2017-2027)
8.6.2. South America Lysosomal Storage Diseases Revenue by Countries (2017-2027)
8.6.3. South America Lysosomal Storage Diseases Revenue (Million USD) by Countries (2017-2027)
8.6.4. Brazil
8.6.4.1. Brazil Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Argentina
8.6.5.1. Argentina Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Columbia
8.6.6.1. Columbia Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.7. Rest of South America
8.6.7.1. Rest of South America Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa
8.7.1. Middle East and Africa Lysosomal Storage Diseases Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Lysosomal Storage Diseases Revenue by Countries (2017-2027)
8.7.3. Middle East and Africa Lysosomal Storage Diseases Revenue (Million USD) by Countries (2017-2027)
8.7.4. Saudi Arabia
8.7.4.1. Saudi Arabia Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. United Arab Emirates
8.7.5.1. United Arab Emirates Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Egypt
8.7.6.1. Egypt Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. Nigeria
8.7.7.1. Nigeria Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. South Africa
8.7.8.1. South Africa Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Genzyme (a Sanofi Company)
9.1.1. Business Overview
9.1.2. Type Portfolio
9.1.3. Strategic Developments
9.1.4. Sales, Revenue and Market Share
9.2. Actelion Ltd.
9.2.1. Business Overview
9.2.2. Type Portfolio
9.2.3. Strategic Developments
9.2.4. Sales, Revenue and Market Share
9.3. Shire PLC
9.3.1. Business Overview
9.3.2. Type Portfolio
9.3.3. Strategic Developments
9.3.4. Sales, Revenue and Market Share
9.4. BioMarin Pharmaceutical Inc.
9.4.1. Business Overview
9.4.2. Type Portfolio
9.4.3. Strategic Developments
9.4.4. Sales, Revenue and Market Share
9.5. Protalix Biotherapeutics Inc.
9.5.1. Business Overview
9.5.2. Type Portfolio
9.5.3. Strategic Developments
9.5.4. Sales, Revenue and Market Share
9.6. Pfizer, Inc.
9.6.1. Business Overview
9.6.2. Type Portfolio
9.6.3. Strategic Developments
9.6.4. Sales, Revenue and Market Share
9.7. Amicus Therapeutics, Inc
9.7.1. Business Overview
9.7.2. Type Portfolio
9.7.3. Strategic Developments
9.7.4. Sales, Revenue and Market Share
9.8. Raptor Pharmaceutical Corp.
9.8.1. Business Overview
9.8.2. Type Portfolio
9.8.3. Strategic Developments
9.8.4. Sales, Revenue and Market Share
10. Global Lysosomal Storage Diseases Market Competition, by Manufacturer
10.1. Global Lysosomal Storage Diseases Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Lysosomal Storage Diseases Price by Region (2017-2017)
10.3. Top 5 Lysosomal Storage Diseases Manufacturer Market Share
10.4. Market Competition Trend
11. Lysosomal Storage Diseases Market Forecast (2027-2023)
11.1. Global Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2027-2023)
11.2. Lysosomal Storage Diseases Market Forecast by Regions (2027-2023)
11.2.1. North America Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.1.1. United States Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.1.2. Canada Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.1.3. Mexico Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.2. Europe Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.2.1. Germany Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.2.2. United Kingdom Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.2.3. France Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.2.4. Russia Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.2.5. Italy Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.2.6. Rest of the Europe Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.3. Asia-Pacific Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.3.1. China Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.3.2. Japan Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.3.3. Korea Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.3.4. India Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.3.5. Southeast Asia Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.3.6. Rest of Asia-Pacific Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.4. South America Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.4.1. Brazil Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.4.2. Argentina Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.4.3. Columbia Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.4.4. Rest of South America Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.5. Middle East and Africa Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.5.1. Saudi Arabia Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.5.2. UAE Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.5.3. Egypt Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.5.4. Nigeria Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.5.5. South Africa Lysosomal Storage Diseases Market Forecast (2027-2023)
11.2.5.6. Rest of MEA Lysosomal Storage Diseases Market Forecast (2027-2023)
11.3. Lysosomal Storage Diseases Market Forecast By Therapy (2027-2023)
11.3.1. Global Lysosomal Storage Diseases Revenue Forecast By Therapy (2027-2023)
11.3.2. Global Lysosomal Storage Diseases Revenue Market Share Forecast By Therapy (2027-2023)
11.4. Lysosomal Storage Diseases Market Forecast By Indication (2027-2023)
11.4.1. Global Lysosomal Storage Diseases Revenue Forecast By Indication (2027-2023)
11.4.2. Global Lysosomal Storage Diseases Revenue Market Share Forecast By Indication (2027-2023)
11.5. Lysosomal Storage Diseases Market Forecast By End User (2027-2023)
11.5.1. Global Lysosomal Storage Diseases Revenue Forecast By End User (2027-2023)
11.5.2. Global Lysosomal Storage Diseases Revenue Market Share Forecast By End User (2027-2023)
12. Research Methodology
12.1.1. Secondary Research
12.1.2. Primary Research
List of Tables
Figure United States Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure Canada Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure Mexico Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure Germany Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure France Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure UK Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure Russia Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure Italy Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure China Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure Japan Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure Korea Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure India Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure Southeast Asia Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure Brazil Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure Egypt Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure Saudi Arabia Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure South Africa Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Figure Nigeria Lysosomal Storage Diseases Revenue (Million USD) and Growth Rate (2017-2023)
Table Global Lysosomal Storage Diseases Revenue and Revenue Share by Therapy (2017-2018)
Figure Global Stem Cell Revenue and Growth Rate (2017-2018)
Figure Global Enzyme Replacement Therapy Revenue and Growth Rate (2017-2018)
Figure Global Substrate Reduction Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Lysosomal Storage Diseases Revenue and Revenue Share by Indication (2017-2018)
Figure Global Pompe’s Syndrome Revenue and Growth Rate (2017-2018)
Figure Global Gaucher’s Disease Revenue and Growth Rate (2017-2018)
Figure Global Fabry Disease Revenue and Growth Rate (2017-2018)
Figure Global Mucopolysaccharidosis Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Lysosomal Storage Diseases Revenue and Revenue Share by End User (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Clinics Revenue and Growth Rate (2017-2018)
Table Global Lysosomal Storage Diseases Revenue by Regions (2017-2018)
Figure North America Lysosomal Storage Diseases Revenue and Growth Rate (2017-2018)
Table North America Lysosomal Storage Diseases Revenue (Million USD) by Countries (2017-2018)
Figure United States Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Lysosomal Storage Diseases Revenue and Growth Rate (2017-2018)
Table Europe Lysosomal Storage Diseases Revenue (Million USD) by Countries (2017-2018)
Figure Germany Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Lysosomal Storage Diseases Revenue and Growth Rate (2017-2018)
Table Asia-Pacific Lysosomal Storage Diseases Revenue (Million USD) by Countries (2017-2018)
Figure China Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Lysosomal Storage Diseases Revenue and Growth Rate (2017-2018)
Table South America Lysosomal Storage Diseases Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Lysosomal Storage Diseases Revenue and Growth Rate (2017-2018)
Table Middle East and Africa Lysosomal Storage Diseases Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2017-2018)
Table Genzyme (a Sanofi Company) Revenue and Market Share (2017-2017)
Table Actelion Ltd. Revenue and Market Share (2017-2017)
Table Shire PLC Revenue and Market Share (2017-2017)
Table BioMarin Pharmaceutical Inc. Revenue and Market Share (2017-2017)
Table Protalix Biotherapeutics Inc. Revenue and Market Share (2017-2017)
Table Pfizer, Inc. Revenue and Market Share (2017-2017)
Table Amicus Therapeutics, Inc Revenue and Market Share (2017-2017)
Table Raptor Pharmaceutical Corp.Revenue and Market Share (2017-2017)
Figure Global Lysosomal Storage Diseases Revenue and Market Share by Manufacturer
Table Global Lysosomal Storage Diseases Price by Region (2017-2017)
Figure Top 5 Lysosomal Storage Diseases Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Lysosomal Storage Diseases Revenue (Millions USD) and Growth Rate (2018-2025)
Table Lysosomal Storage Diseases Market Forecast by Regions (2018-2025)
Figure North America Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure United States Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Canada Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Mexico Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Europe Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Germany Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure United Kingdom Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure France Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Russia Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Italy Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Asia-Pacific Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure China Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Japan Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Korea Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure India Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Southeast Asia Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure South America Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Brazil Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Argentina Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Columbia Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Rest of South America Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Middle East and Africa Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Saudi Arabia Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure UAE Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Egypt Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Nigeria Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure South Africa Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Rest of MEA Lysosomal Storage Diseases Market Forecast (2018-2025)
Figure Global Lysosomal Storage Diseases Revenue Forecast by Therapy (2018-2025)
Figure Global Lysosomal Storage Diseases Revenue Market Share Forecast by Therapy (2018-2025)
Figure Global Lysosomal Storage Diseases Revenue Forecast by Indication (2018-2025)
Figure Global Lysosomal Storage Diseases Revenue Market Share Forecast by Indication (2018-2025)
Figure Global Lysosomal Storage Diseases Revenue Forecast by End User (2018-2025)
Figure Global Lysosomal Storage Diseases Revenue Market Share Forecast by End User (2018-2025)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|